Hives That Won’t Go Away: What Are Your Treatment Options?

Confirm that the spots behave like ordinary hives

A single hive generally appears suddenly, itches, and resolves without leaving a mark within 24 hours, even while new welts develop elsewhere. Deeper swelling can last longer. Record when each area starts and clears rather than judging only the total length of the flare. A photograph beside a clock or date can show whether one lesion remained fixed, and a list of every prescription, supplement, and over-the-counter medicine can reveal aggravating factors.

Painful or burning lesions, spots that stay in the same place beyond a day, bruising or discoloration after they fade, fever, joint symptoms, or unexplained illness do not fit the usual pattern and deserve medical review. Swelling without any hives also changes the evaluation. These distinctions can point away from ordinary urticaria and prevent months of treating a different rash as if it were a histamine-driven hive.

Related care: Conditions we treat. Compare skin, immune, and allergy conditions that can resemble or accompany hives.

Separate spontaneous hives from reproducible physical triggers

Chronic spontaneous urticaria means hives or angioedema continue for at least six weeks without a consistent external trigger. Chronic inducible urticaria follows a repeatable stimulus such as cold, heat, pressure, scratching, sunlight, vibration, sweating, or exercise. A person can have more than one form, so a diary should capture temperature, activity, pressure from straps or clothing, illness, menstrual timing, and medicine exposure without turning every meal into a suspected allergy.

Most chronic spontaneous hives are not explained by a hidden food allergy, and broad allergy panels can produce positive results that do not match symptoms. The history and examination guide a limited workup, with additional tests selected only when a specific clue would change the diagnosis or plan. This approach reduces unnecessary diets while still investigating features such as isolated angioedema, systemic symptoms, or an unusual lesion duration.

Related care: Hives and angioedema. Review the clinical pathway for recurrent welts and swelling.

Use the first treatment step consistently and safely

Current urticaria guidance starts with a second-generation H1 antihistamine for most chronic hives because these medicines are generally less sedating than older antihistamines. The clinician should choose the medicine and schedule around age, pregnancy, kidney or liver disease, other medicines, driving, and prior side effects. Taking a plan consistently often provides clearer information than switching products each time a welt appears.

If the standard plan does not control symptoms, guidelines allow a clinician to increase a second-generation antihistamine dose within a structured treatment sequence. That is not an instruction to multiply a dose independently or mix several products with the same ingredient. Bring the exact bottles or photographs of labels to the visit, including sleep aids and cold medicines, so duplicate antihistamines and sedation risks can be identified.

Escalate treatment when antihistamines are not enough

For chronic spontaneous urticaria that remains uncontrolled despite an adequate high-dose second-generation antihistamine plan, a specialist may discuss add-on treatment such as omalizumab. The decision should confirm the diagnosis, document symptom burden, and explain administration, safety monitoring, expected review points, insurance authorization, and what counts as a meaningful response. Omalizumab is not a rescue medicine for a sudden severe allergic reaction.

More refractory disease may lead to discussion of other specialist-supervised medicines, each with its own monitoring and risk profile. Long-term systemic corticosteroids are not a routine maintenance strategy for chronic urticaria because repeated exposure can cause substantial harm. A brief course may be considered in selected severe flares, but only within an individualized plan. Treatment should be reassessed periodically because disease activity can change or remit.

Track control instead of chasing a perfect trigger list

For two to four weeks, record hive days, itch severity, swelling, sleep disruption, medicine use, missed work or school, and any repeatable physical trigger. Photograph representative flares and note how long one marked welt lasts. A short, structured record is more useful than a long list of every food eaten. It also shows whether treatment is reducing daily burden even if an occasional hive still appears.

Bring prior emergency visits, laboratory results, medication trials with dose and duration, and a family history of swelling. Ask what diagnosis is being treated, which result would change the plan, how response will be measured, and when therapy can be stepped down. If hives repeatedly follow one food, medicine, or sting within a short and consistent interval, describe that exact sequence so a separate immediate-allergy evaluation can be considered.

Know when swelling is an emergency

Call emergency services for trouble breathing, throat tightness, a hoarse or changing voice, tongue swelling, faintness, confusion, bluish or gray lips, or a rapid reaction affecting more than one body system. Follow the person’s emergency action plan and use prescribed epinephrine when the plan directs it. Do not wait for an antihistamine to reverse airway or circulation symptoms, and do not drive yourself during a severe reaction.

Lip or eyelid swelling without breathing symptoms still warrants prompt advice when it is new, severe, progressing, or associated with a new medicine. Angioedema that occurs without hives can follow a different pathway and may not respond to the same treatment. Keep emergency instructions separate from the daily chronic-hives plan so everyone in the household knows which symptoms require immediate action and which belong in the routine symptom record.

A recurring six-week pattern is different from one lasting spot

An individual hive usually fades within 24 hours without bruising, although a new one may appear elsewhere. Chronic urticaria describes recurring hives for more than six weeks; it does not mean that one unchanged lesion has lasted six weeks. A persistent, painful, or bruising spot deserves a different assessment.

When hives remain uncontrolled, the clinician can review the diagnosis and a stepped treatment plan. Current AAAAI guidance discusses antihistamines, injectable options, and a newer oral option for appropriate patients. Drug choice and eligibility depend on the history, other conditions, and current labeling; do not increase or combine medicines on the basis of a treatment ladder online.